Perioperative Management - USMLE Step 2

SECTION 1

Historical Context & Motivation

The evolution of perioperative management reflects centuries of progress in understanding how to minimize the physiological insult of surgery and maximize patient survival. Before the advent of anesthesia and antisepsis, surgical mortality was staggering—often exceeding 40% for major operations—and the concept of systematically preparing a patient for surgery did not exist. Surgeons operated rapidly out of necessity, with no preoperative risk stratification and no structured postoperative care. The recognition that outcomes could be dramatically improved through attention to the phases surrounding the operation itself represented a paradigm shift in surgical thinking, transforming surgery from a last-resort intervention into a planned, optimizable process.

1846 • Ether Anesthesia Demonstrated

William Morton's public demonstration of ether anesthesia at Massachusetts General Hospital fundamentally altered the surgical experience, enabling controlled, pain-free operations and opening the door to longer, more complex procedures that demanded structured preoperative planning.

1867 • Lister Introduces Antisepsis

Joseph Lister's application of carbolic acid antisepsis dramatically reduced postoperative infection rates, establishing the principle that perioperative infection control is essential to surgical success and laying groundwork for modern sterile technique.

1977 • Goldman Cardiac Risk Index

Lee Goldman published the first multifactorial cardiac risk index for noncardiac surgery, inaugurating the era of systematic, evidence-based preoperative risk stratification. This tool allowed clinicians to quantify cardiac risk and guide perioperative decision-making.

1999 • ACC/AHA Perioperative Guidelines

The American College of Cardiology and American Heart Association published comprehensive perioperative cardiovascular evaluation guidelines, standardizing the approach to preoperative cardiac assessment and establishing the stepwise algorithm still used in modified form today.

2010s • Enhanced Recovery After Surgery (ERAS)

ERAS protocols emerged as multimodal, evidence-based care pathways designed to reduce surgical stress, accelerate recovery, and shorten hospital stays. These protocols integrated preoperative optimization, intraoperative technique, and postoperative management into a unified framework.

The central question that perioperative management addresses is deceptively simple: how do we ensure that a patient enters the operating room in the best possible physiological state, tolerates the stress of surgery, and recovers with minimal complications? Answering this question requires integrating knowledge from cardiology, pulmonology, hematology, endocrinology, and pharmacology into a cohesive management plan. For USMLE Step 2, understanding the systematic approach to preoperative evaluation, intraoperative monitoring, and postoperative complication management is essential.

SECTION 2

Core Principles of Perioperative Care

Perioperative management is organized around three temporal phases—preoperative, intraoperative, and postoperative—each with distinct goals, assessments, and interventions. The overarching principles that guide clinical decision-making across all three phases can be distilled into several foundational concepts that every surgical team must internalize. These principles are not isolated; they interact dynamically throughout the patient's surgical journey.

Risk Stratification

Systematically assess patient comorbidities, functional capacity, and surgical complexity to predict perioperative complications. Tools such as the Revised Cardiac Risk Index (RCRI) and ASA Physical Status Classification quantify risk and guide management decisions.

Optimization Before Incision

Correct modifiable risk factors before surgery. This includes glycemic control in diabetics (target HbA1c < 8%), smoking cessation ideally ≥ 4 weeks preoperatively, nutritional repletion, and management of anemia. Medication reconciliation—including decisions about anticoagulants, antihypertensives, and chronic medications—is critical.

Intraoperative Vigilance

Continuous monitoring of hemodynamics, temperature, oxygenation, and fluid balance during surgery enables early detection of physiologic derangements. Appropriate antibiotic prophylaxis, DVT prevention, and maintenance of normothermia are standardized safety measures.

Complication Anticipation

Postoperative complications—including surgical site infections, venous thromboembolism, atelectasis, ileus, urinary retention, and delirium—are predictable based on patient and surgical risk factors. Early ambulation, incentive spirometry, and structured pain management reduce their incidence.

Multidisciplinary Coordination

Effective perioperative care requires seamless communication between surgeons, anesthesiologists, internists, nurses, pharmacists, and allied health professionals. Standardized checklists—most notably the WHO Surgical Safety Checklist—reduce errors and improve outcomes.

✦

KEY TAKEAWAY

Think of perioperative management like preparing for a cross-country flight. The preoperative phase is your pre-flight inspection—checking fuel, systems, and weather conditions. The intraoperative phase is the flight itself, requiring constant instrument monitoring and adjustments to turbulence. The postoperative phase is the landing and post-flight checks—this is where many "crashes" happen if the crew relaxes too early. Just as aviation safety improved dramatically through checklists and crew resource management, surgical safety has followed a remarkably similar trajectory.

SECTION 3

The Perioperative Timeline

The perioperative timeline illustrating the three phases of surgical care: preoperative assessment and optimization (violet), intraoperative monitoring and safety (pink), and postoperative recovery with anticipated complication timelines (cyan). Note how each phase feeds into the next; inadequate preoperative optimization increases intraoperative risk, which in turn elevates postoperative complication rates.

The diagram above represents the conceptual framework for perioperative management. In the preoperative phase, the focus is on identifying and modifying risk factors through a comprehensive history and physical examination, targeted laboratory testing, and evidence-based risk indices such as the RCRI. The intraoperative phase centers on real-time monitoring and safety protocols, including the WHO Surgical Safety Checklist, which has been shown to reduce mortality by approximately 47% in diverse settings. The postoperative phase requires systematic complication surveillance. A high-yield concept for USMLE Step 2 is the timing of postoperative fever: atelectasis within the first 48 hours, followed by urinary tract infection (days 3–5), wound infection (days 5–7), and deep venous thrombosis or pulmonary embolism (days 5–14). This "Wind, Water, Wound, Walk, Wonder drug" mnemonic remains a clinically useful framework.

SECTION 4

Preoperative Cardiac Risk Assessment

Cardiac complications remain the leading cause of perioperative morbidity and mortality in noncardiac surgery. The systematic approach to perioperative cardiac risk evaluation follows the ACC/AHA stepwise algorithm, which integrates emergency status, active cardiac conditions, surgical risk, functional capacity, and clinical risk factors to determine whether a patient can proceed to surgery, requires further testing, or needs intervention. Understanding this algorithm is essential for USMLE Step 2.

The Revised Cardiac Risk Index (RCRI / Lee Index)

The Revised Cardiac Risk Index assigns one point for each of six independent predictors of major cardiac events in noncardiac surgery: (1) high-risk surgery (intraperitoneal, intrathoracic, or suprainguinal vascular), (2) history of ischemic heart disease, (3) history of congestive heart failure, (4) history of cerebrovascular disease, (5) insulin-dependent diabetes mellitus, and (6) preoperative serum creatinine > 2.0 mg/dL. The estimated risk of major cardiac events increases with the number of risk factors present.

RCRI Score	Number of Risk Factors	Estimated Major Cardiac Event Rate	Risk Category
0	0	≈ 3.9%	Low
1	1	≈ 6.0%	Moderate
2	2	≈ 10.1%	Elevated
≥ 3	3 or more	≈ 15%+	High

RCRI scoring and estimated rates of major cardiac complications

Functional Capacity Assessment (METs)

A patient's functional capacity, measured in metabolic equivalents (METs), is a critical determinant of perioperative cardiac risk. One MET represents the resting metabolic rate. A patient who can achieve ≥ 4 METs of activity—equivalent to climbing one flight of stairs, walking uphill, or performing heavy housework—generally has adequate cardiopulmonary reserve to tolerate most surgeries without additional cardiac testing. Patients unable to achieve 4 METs (or whose functional capacity is unknown) with elevated RCRI scores may warrant further evaluation with pharmacologic stress testing or echocardiography.

METABOLIC EQUIVALENTS

1 MET = 3.5 mL O₂ / kg / min

Where 1 MET represents basal resting oxygen consumption. Activities of daily living require approximately 1–4 METs, while vigorous exercise (running, competitive sports) requires > 10 METs. The threshold of 4 METs represents the approximate metabolic demand of most surgical procedures.

ℹ

ACC/AHA Algorithm Key Steps

Step 1: Is this an emergency? If yes, proceed to surgery with risk factor management. Step 2: Does the patient have an active cardiac condition (e.g., unstable angina, decompensated HF, significant arrhythmia, severe valvular disease)? If yes, postpone for evaluation. Step 3: Is the surgery low-risk (e.g., cataract, endoscopy, superficial procedures)? If yes, proceed. Step 4: Can the patient achieve ≥ 4 METs without symptoms? If yes, proceed. Step 5: If functional capacity is poor or unknown, consider the number of clinical risk factors (RCRI) and the procedural risk to guide the decision for additional testing.

SECTION 5

Perioperative Medication Management

One of the most frequently tested topics on USMLE Step 2 is the perioperative management of chronic medications. Certain drugs must be continued through surgery to prevent rebound phenomena or withdrawal, while others must be held to avoid bleeding, hemodynamic instability, or metabolic complications. The following table summarizes the key medication classes and their perioperative management. It is essential to understand the physiological rationale behind each recommendation, not merely memorize a list.

Perioperative medication decision algorithm. The primary decision points are whether discontinuation carries withdrawal or rebound risk (favoring continuation) and whether the medication increases surgical bleeding or hemodynamic instability (favoring holding). Anticoagulants requiring bridging therapy represent a particularly nuanced decision requiring individualized thromboembolic risk assessment.

High-Yield Medication Details

Several medication management scenarios deserve special attention. Beta-blockers should never be abruptly discontinued in patients already taking them, as withdrawal can trigger rebound tachycardia and hypertension, precipitating myocardial ischemia. However, initiating beta-blockers de novo on the day of surgery is harmful (per the POISE trial), so they should be started well in advance if indicated. Chronic corticosteroids suppress the hypothalamic-pituitary-adrenal axis; patients on chronic steroids (equivalent to ≥ 5 mg prednisone daily for > 3 weeks) require stress-dose steroids (typically hydrocortisone 100 mg IV at induction, then 50 mg every 8 hours for 24–72 hours) to prevent adrenal crisis. Warfarin is held 5 days preoperatively, and bridging with low-molecular-weight heparin is considered only for patients at high thromboembolic risk (e.g., mechanical heart valves, recent VTE within 3 months, or high-risk atrial fibrillation with CHA₂DS₂-VASc ≥ 7).

⚠

Antibiotic Prophylaxis Timing

Surgical antibiotic prophylaxis should be administered within 60 minutes of incision (120 minutes for vancomycin and fluoroquinolones due to longer infusion times). Cefazolin is the standard agent for most clean and clean-contaminated cases. Prophylaxis should be discontinued within 24 hours postoperatively; prolonged courses do not reduce SSI and promote resistance.

SECTION 6

Worked Example: Preoperative Evaluation

The following clinical vignette walks through the perioperative evaluation of a patient presenting for elective surgery, demonstrating the systematic application of the ACC/AHA algorithm, RCRI scoring, and medication management principles.

Case: 68-year-old Male Presenting for Elective Colectomy

1
Step 1 — Gather Clinical Data

A 68-year-old male with a history of type 2 diabetes mellitus (on insulin and metformin), hypertension (on lisinopril and metoprolol), coronary artery disease with a drug-eluting stent placed 14 months ago (on aspirin and clopidogrel), and a serum creatinine of 2.3 mg/dL presents for elective sigmoid colectomy for recurrent diverticulitis. He reports being able to walk to the mailbox (approximately 100 meters) but becomes short of breath climbing stairs.
2
Step 2 — Apply ACC/AHA Algorithm

Is this an emergency? No, it is elective. Does the patient have an active cardiac condition? No unstable angina, decompensated heart failure, significant arrhythmia, or severe valvular disease. Is this low-risk surgery? No—sigmoid colectomy is intraperitoneal and therefore high-risk. What is functional capacity? The patient can walk on flat ground but cannot climb stairs without dyspnea, indicating < 4 METs functional capacity.

Functional capacity < 4 METs → proceed to clinical risk factor assessment
3
Step 3 — Calculate RCRI Score

High-risk surgery (intraperitoneal): +1. History of ischemic heart disease (prior stent): +1. Insulin-dependent diabetes: +1. Creatinine > 2.0 mg/dL: +1. No history of CHF or cerebrovascular disease.

RCRI = 4 → High risk (estimated major cardiac event rate > 15%)
4
Step 4 — Decide on Further Testing

With an RCRI ≥ 3 and functional capacity < 4 METs for an elevated-risk procedure, pharmacologic stress testing (e.g., dobutamine stress echocardiography or nuclear myocardial perfusion imaging) is reasonable if the result would change management. If stress testing reveals significant ischemia, cardiology consultation for potential revascularization may be warranted before elective surgery. If stress testing is normal or shows minor fixed defects, proceed with perioperative beta-blocker optimization and close hemodynamic monitoring.

Order pharmacologic stress test → Results will determine whether to proceed or refer to cardiology
5
Step 5 — Medication Management Plan

Continue metoprolol (beta-blocker) perioperatively—do not discontinue. Continue aspirin given coronary stent history. Hold clopidogrel 5–7 days preoperatively after discussion with cardiology (stent placed > 12 months ago, so dual antiplatelet interruption is acceptable). Hold lisinopril (ACE inhibitor) on the morning of surgery to prevent refractory intraoperative hypotension. Hold metformin on the day of surgery and restart when postoperative renal function is confirmed. Administer cefazolin 2 g IV within 60 minutes of incision. Use an insulin sliding scale for perioperative glycemic control with a target glucose of 140–180 mg/dL.

Continue: metoprolol, aspirin. Hold: clopidogrel (5–7 days), lisinopril (day of), metformin (day of). Add: cefazolin prophylaxis, insulin sliding scale, DVT prophylaxis.
6
Step 6 — Postoperative Plan

Postoperatively, monitor telemetry for 48–72 hours given elevated cardiac risk. Reinstate DVT prophylaxis with subcutaneous heparin or enoxaparin. Encourage early ambulation and incentive spirometry. Monitor for postoperative ileus (common after colectomy), surgical site infection, and anastomotic leak (typically presents on POD 5–7 with fever, tachycardia, abdominal pain, and leukocytosis). Resume clopidogrel when surgical hemostasis is assured. Restart lisinopril when the patient is hemodynamically stable and tolerating oral intake.

Comprehensive postoperative monitoring with systematic complication surveillance and medication resumption plan

SECTION 7

Postoperative Complications: Recognition & Management

Understanding the timing, presentation, and management of postoperative complications is among the highest-yield perioperative topics for USMLE Step 2. Complications can be broadly categorized by their temporal relationship to surgery, organ system involvement, and severity. The following table presents the major postoperative complications organized by their expected onset, key diagnostic features, and management approach.

Complication	Typical Onset	Key Presentation	Initial Management
Atelectasis	POD 0–2	Low-grade fever, decreased breath sounds, tachypnea	Incentive spirometry, early ambulation, deep breathing exercises
Pneumonia	POD 3–5	Productive cough, fever, consolidation on CXR, leukocytosis	Sputum culture, empiric antibiotics, continued pulmonary toilet
UTI	POD 3–5	Fever, dysuria, positive UA; often catheter-associated	Remove catheter ASAP, urine culture, targeted antibiotics
SSI (superficial)	POD 5–7	Wound erythema, warmth, purulent drainage, fever	Open and drain wound, wound culture, antibiotics if cellulitis
DVT / PE	POD 5–14	Calf pain/swelling (DVT); sudden dyspnea, pleuritic chest pain, tachycardia (PE)	Duplex US (DVT), CTPA (PE), therapeutic anticoagulation
Anastomotic leak	POD 5–7	Fever, tachycardia, peritonitis, feculent drain output, leukocytosis	CT with contrast, NPO, antibiotics, surgical re-exploration vs. percutaneous drainage
Postoperative ileus	POD 3–5	Abdominal distension, absent bowel sounds, nausea, no flatus	NPO, NGT if vomiting, correct electrolytes (K⁺, Mg²⁺), early ambulation
Postop delirium	POD 1–5	Acute confusion, fluctuating consciousness, agitation; common in elderly	Identify precipitant (infection, pain, meds, metabolic), reorientation, avoid benzodiazepines

Major postoperative complications by timing, presentation, and management

🌡️

FEVER TIMING MNEMONIC

The classic "5 W's" of postoperative fever provide a systematic approach: Wind (atelectasis/pneumonia, POD 1–2), Water (UTI, POD 3–5), Wound (SSI, POD 5–7), Walk (DVT/PE, POD 5–14), and Wonder drugs (drug fever, medication reaction, any time). While this mnemonic is imperfect and does not encompass all causes, it provides an organized framework for evaluating the febrile postoperative patient that is heavily tested on USMLE Step 2.

SECTION 8

Enhanced Recovery & Special Populations

Modern perioperative management has evolved beyond the traditional approach of prolonged preoperative fasting, liberal opioid analgesia, and extended bed rest. Enhanced Recovery After Surgery (ERAS) protocols represent the cutting edge of evidence-based perioperative care, integrating over 20 individual elements into a comprehensive care pathway. Additionally, certain patient populations—including the elderly, those with obstructive sleep apnea, patients on chronic anticoagulation, and those with implanted cardiac devices—require specialized perioperative considerations that extend beyond standard algorithms.

Component	Traditional Approach	ERAS Protocol
Preoperative fasting	NPO after midnight	Clear liquids up to 2 hours pre-op; carbohydrate loading
Bowel preparation	Routine mechanical prep	Selective use; combination MBP + oral antibiotics if used
Analgesia	Opioid-centric (PCA)	Multimodal: acetaminophen, NSAIDs, gabapentinoids, regional blocks, opioid-sparing
IV fluids	Liberal crystalloid	Goal-directed, balanced crystalloid; avoid overhydration
Drains & tubes	Routine NGT, drains, Foley	Avoid routine drains/NGT; early Foley removal
Diet	Stepwise (clears → full)	Early oral feeding on POD 0–1
Mobilization	Bed rest POD 1–2	Out of bed on POD 0; progressive ambulation
Outcome	Avg LOS 7–10 days (colectomy)	Avg LOS 3–5 days with reduced complications

Traditional vs. ERAS perioperative protocols for colorectal surgery

Special populations present unique perioperative challenges. Elderly patients are at elevated risk for postoperative delirium, which occurs in up to 50% of surgical patients over age 65 and is associated with increased mortality, prolonged hospitalization, and long-term cognitive decline. Prevention strategies include avoiding anticholinergic medications, minimizing benzodiazepines, maintaining sleep-wake cycles, early mobilization, and treating underlying precipitants (infection, pain, electrolyte abnormalities). Patients with obstructive sleep apnea (OSA) are at increased risk for postoperative respiratory complications, including oxygen desaturation, airway obstruction, and aspiration. They should be identified preoperatively using the STOP-BANG questionnaire, and postoperative management includes CPAP continuation, upright positioning, opioid-sparing analgesia, and continuous pulse oximetry monitoring.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

A 55-year-old woman on chronic prednisone 10 mg daily for rheumatoid arthritis is scheduled for an elective total hip replacement. Her surgeon asks whether any special perioperative considerations are needed regarding her steroid use. What is the primary concern, and what is the recommended management?

Show answer

The primary concern is adrenal insufficiency due to hypothalamic-pituitary-adrenal (HPA) axis suppression from chronic exogenous glucocorticoid use. Patients taking the equivalent of ≥ 5 mg prednisone daily for more than 3 weeks may have an attenuated cortisol stress response, placing them at risk for hemodynamic instability (refractory hypotension) under surgical stress. The recommended management is to administer stress-dose steroids—typically hydrocortisone 100 mg IV at induction, followed by 50 mg IV every 8 hours for 24–72 hours depending on surgical complexity, then rapidly taper back to the patient's baseline dose. This ensures adequate cortisol levels during the perioperative period while avoiding prolonged supraphysiologic dosing.

Question 2: BASIC CALCULATION

A 72-year-old man with a history of prior MI, insulin-dependent diabetes, and a creatinine of 2.5 mg/dL is scheduled for an open abdominal aortic aneurysm repair. Calculate his RCRI score and state the approximate risk of a major perioperative cardiac event.

Show answer

The six RCRI criteria are: (1) high-risk surgery, (2) ischemic heart disease, (3) congestive heart failure, (4) cerebrovascular disease, (5) insulin-dependent diabetes, and (6) creatinine > 2.0 mg/dL. This patient has: high-risk surgery (suprainguinal vascular repair, +1), ischemic heart disease (prior MI, +1), insulin-dependent diabetes (+1), and creatinine 2.5 mg/dL (+1). No mention of CHF or cerebrovascular disease. RCRI = 4 points, placing him in the high-risk category with an estimated major cardiac event rate of > 15%. Given this high risk, the elevated-risk procedure, and the need to assess functional capacity, pharmacologic stress testing is warranted to evaluate for significant myocardial ischemia before proceeding with elective repair.

Question 3: INTERMEDIATE

A 60-year-old woman on warfarin for a mechanical mitral valve (St. Jude) presents for elective cholecystectomy. Her INR is 2.8. Describe the perioperative anticoagulation management plan, including timing of warfarin cessation, bridging strategy, and postoperative resumption.

Show answer

A mechanical mitral valve represents a high thromboembolic risk indication, and bridging anticoagulation is strongly recommended. The management plan is: (1) Hold warfarin 5 days preoperatively to allow the INR to drift to ≤ 1.5. (2) Begin therapeutic-dose LMWH (e.g., enoxaparin 1 mg/kg subcutaneously every 12 hours) approximately 3 days before surgery when the INR falls below 2.0. (3) Administer the last dose of LMWH 24 hours before surgery (or 12 hours before if using the every-12-hour regimen). (4) Check INR on the morning of surgery to confirm ≤ 1.5. (5) Postoperatively, restart LMWH 48–72 hours after surgery once surgical hemostasis is confirmed. (6) Restart warfarin on POD 1 (evening dose) and continue LMWH bridging until the INR is therapeutic (2.5–3.5 for mechanical mitral valve) for at least 2 consecutive days. This approach balances the high thromboembolic risk of a mechanical mitral valve against surgical bleeding risk.

Question 4: APPLIED

On postoperative day 5 following a right hemicolectomy, a 65-year-old male develops a fever of 38.9°C, tachycardia (HR 110), abdominal distension, and diffuse tenderness with guarding. His WBC is 18,000/μL. He had been progressing well until this point, tolerating a regular diet, and his Jackson-Pratt drain output had been minimal serous fluid. Today, the JP drain output has become turbid and bilious-appearing. Provide a systematic differential diagnosis, the most likely diagnosis, and the initial management steps.

Show answer

Using the postoperative fever timing framework, POD 5 raises concern for wound infection, UTI, pneumonia, and DVT/PE. However, the combination of fever, tachycardia, leukocytosis, peritoneal signs, and bilious/turbid drain output on POD 5 after a colectomy is highly suggestive of an anastomotic leak with developing peritonitis. This is the most likely and most dangerous diagnosis. The differential also includes intra-abdominal abscess, postoperative ileus with bacterial translocation, and C. difficile colitis (particularly if the patient received perioperative antibiotics). Initial management includes: (1) NPO and IV fluid resuscitation, (2) blood cultures and broad-spectrum antibiotics covering gram-negative and anaerobic organisms (e.g., piperacillin-tazobactam or meropenem), (3) emergent CT abdomen/pelvis with IV and oral contrast to confirm the leak and assess for free air or abscess, and (4) surgical consultation for likely re-exploration, washout, and either primary re-anastomosis or diverting ostomy with end ileostomy depending on findings.

Question 5: CRITICAL THINKING

A hospital quality improvement committee notes that their surgical site infection rate for elective colorectal cases is 12%, significantly above the national benchmark of 5–8%. The committee has already confirmed appropriate antibiotic selection (cefazolin + metronidazole) and timing (within 60 minutes of incision). Propose a comprehensive, evidence-based perioperative intervention bundle that addresses the remaining modifiable risk factors for SSI, and explain the mechanism by which each intervention reduces infection risk.

Show answer

A comprehensive SSI reduction bundle should address patient, environmental, and procedural factors beyond antibiotic prophylaxis. Proposed interventions include: (1) Preoperative chlorhexidine bathing (reduces skin microbial burden, particularly gram-positive organisms, by disrupting bacterial cell membranes). (2) Intraoperative normothermia maintenance using forced-air warming blankets and warmed IV fluids (hypothermia impairs neutrophil function, oxygen delivery to tissues, and collagen synthesis). (3) Perioperative glycemic control targeting glucose 140–180 mg/dL (hyperglycemia impairs leukocyte chemotaxis, phagocytosis, and oxidative burst). (4) Supplemental oxygen therapy maintaining FiO₂ ≥ 0.8 intraoperatively (increased tissue oxygen tension enhances neutrophil oxidative killing and collagen deposition). (5) Appropriate hair removal using clippers rather than razors if needed (razors create microabrasions that serve as bacterial entry points). (6) Mechanical bowel preparation combined with oral antibiotics (neomycin + erythromycin) the day before surgery (reduces intraluminal bacterial load at the anastomosis). (7) Redosing of prophylactic antibiotics intraoperatively if the procedure exceeds 2 half-lives of the antibiotic or blood loss exceeds 1500 mL. (8) Changing gloves and using a separate closing tray for fascial closure to reduce contamination from the operative field. Each element targets a specific pathophysiological mechanism contributing to SSI, and bundled implementation has been shown to achieve greater risk reduction than any single intervention alone.

SUMMARY

Perioperative Management — Summary

Summary

Perioperative management encompasses a systematic approach to patient care across three phases. The preoperative phase focuses on risk stratification using tools such as the Revised Cardiac Risk Index (RCRI) and functional capacity assessment (METs), optimization of modifiable risk factors (glycemic control, smoking cessation, anemia correction), and critical medication management decisions—continuing beta-blockers and statins, holding ACE inhibitors and anticoagulants, and providing stress-dose steroids for patients on chronic glucocorticoids.

The intraoperative phase requires adherence to the WHO Surgical Safety Checklist, timely antibiotic prophylaxis (within 60 minutes of incision), and vigilant hemodynamic monitoring. The postoperative phase demands systematic complication surveillance guided by the temporal pattern of complications: atelectasis (POD 0–2), UTI and pneumonia (POD 3–5), SSI and anastomotic leak (POD 5–7), and DVT/PE (POD 5–14). Modern ERAS protocols have demonstrated that multimodal, evidence-based care bundles emphasizing early feeding, multimodal analgesia, and early ambulation significantly reduce length of stay and complication rates.